Nanomedicines reveal how PBOV1 promotes hepatocellular carcinoma for effective gene therapy
Novel therapeutic strategies are needed to improve the treatment outcome of hepatocellular carcinoma. Here, the authors develop a theranostical targeted nanomedicine platform that reveals the key oncogenic role of PBOV1 in hepatocellular carcinoma.
Guardado en:
Autores principales: | Yu Guo, Zhiqiang Wu, Shunli Shen, Ruomi Guo, Jing Wang, Weiwei Wang, Kun Zhao, Ming Kuang, Xintao Shuai |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/df628571a91a4d879af5c3772f6a5b78 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Overexpression of PIK3R1 promotes hepatocellular carcinoma progression
por: Ai,Xuejun, et al.
Publicado: (2018) -
SLC41A3 Exhibits as a Carcinoma Biomarker and Promoter in Liver Hepatocellular Carcinoma
por: Qimeng Chang, et al.
Publicado: (2021) -
Experiment on Inhibiting NEK7 to Promote Apoptosis of Hepatocellular Carcinoma Cells
por: SONG Yanzhou, et al.
Publicado: (2021) -
Nucleolar protein 6 promotes cell proliferation and acts as a potential novel prognostic marker for hepatocellular carcinoma
por: Lei Meng, et al.
Publicado: (2021) -
FMRP regulates STAT3 mRNA localization to cellular protrusions and local translation to promote hepatocellular carcinoma metastasis
por: Zhifa Shen, et al.
Publicado: (2021)